Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Guardant Health Inc
(NQ:
GH
)
22.16
+0.36 (+1.65%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Guardant Health Inc
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Earlier Screening and Aging Population Driving Surging Growth in Colorectal Diagnostics Demand
November 11, 2021
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – November 11, 2021 – New recommendations for colorectal cancer (CRC) screening by both the US Preventative Services Task Force...
Via
FinancialNewsMedia
Guardant Health to Participate in the 2021 Stifel Healthcare Conference
November 08, 2021
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Registers 27% Revenue Growth In Q3, Tops Consensus; Backs FY21 Guidance
November 05, 2021
Guardant Health Inc (NASDAQ: GH) reported Q3 sales of $94.8 million, +27% Y/Y, beating the Wall Street estimate of $92.64 million. Guardant's Q3 precision oncology...
Via
Benzinga
Guardant Health Inc (GH) Q3 2021 Earnings Call Transcript
November 05, 2021
GH earnings call for the period ending October 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Guardant Health: Q3 Earnings Insights
November 04, 2021
Guardant Health (NASDAQ:GH) reported its Q3 earnings results on Thursday, November 4, 2021 at 04:03 PM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
Guardant Health Reports Third Quarter 2021 Financial Results
November 04, 2021
From
Guardant Health, Inc.
Via
Business Wire
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...
Via
Benzinga
Exposures
COVID-19
Guardant Health and The Royal Marsden NHS Foundation Trust Announce Partnership to Establish First Guardant Health Liquid Biopsy Testing Service Based in the United Kingdom
November 03, 2021
From
Guardant Health, Inc.
Via
Business Wire
Data Presented at ACG Shows Guardant Health’s Blood-Based Test Accurately Detects Early-Stage Colorectal Cancer
October 25, 2021
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Appoints Myrtle Potter to Its Board of Directors
October 20, 2021
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to Report Third Quarter Financial Results on November 4, 2021
October 08, 2021
From
Guardant Health, Inc.
Via
Business Wire
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...
Via
Benzinga
Guardant Health Initiates ORACLE Study to Evaluate Performance of Guardant Reveal™ Blood Test to Predict Recurrence Across Early-Stage Cancers
October 05, 2021
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Will Not Go With NeoGenomics Deal: Bloomberg
October 04, 2021
Guardant Health Inc (NASDAQ: GH) has decided not to pursue a potential acquisition of NeoGenomics Inc (NASDAQ: NEO), Bloomberg reported citing people...
Via
Benzinga
54 Biggest Movers From Friday
October 04, 2021
Check out these big penny stock gainers and losers Losers Spire Global, Inc.. (NYSE: SPIR) shares fell 43.3% to close at $7.10 on Friday. Spire Global, Inc....
Via
Benzinga
Why Guardant Health Is Down More Than 14% Friday
October 01, 2021
Investors aren't fans of an acquisition the diagnostics company is rumored to be considering.
Via
The Motley Fool
12 Health Care Stocks Moving In Friday's Intraday Session
October 01, 2021
Gainers Biomerica (NASDAQ:BMRA) stock moved upwards by 39.33% to $6.27 during Friday's regular session. As of 12:30 EST, Biomerica's stock is trading at a volume...
Via
Benzinga
Guardant Health Weighing NeoGenomics Acquisition: Bloomberg
October 01, 2021
Bloomberg reported that Guardant Health Inc (NASDAQ: GH) is reportedly exploring an acquisition of NeoGenomics Inc (NASDAQ: NEO), citing people familiar...
Via
Benzinga
Investing in These 2 Top Stocks Could Make You a Millionaire Retiree
September 30, 2021
Both of these companies boast exciting growth prospects.
Via
The Motley Fool
Topics
Retirement
Exposures
Pension
Guardant Health Showcases Data at ESMO 2021 Demonstrating Utility of Guardant360® Liquid Biopsy to Obtain Comprehensive Molecular Information to Guide Targeted Therapy Options for Late-Stage Cancers
September 15, 2021
From
Guardant Health, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
September 10, 2021
Gainers Hepion Pharmaceuticals (NASDAQ:HEPA
Via
Benzinga
Return on Capital Employed Insights for Guardant Health
September 01, 2021
After pulling data from Benzinga Pro it seems like during Q2, Guardant Health's (NASDAQ:GH) reported sales totaled $92.10 million. Despite a 9.48% in earnings, the company posted...
Via
Benzinga
Guardant Health Expands Precision Oncology Offerings
August 11, 2021
Guardant’s Q2 revenues grew 39% over the year to $92.1 million, ahead of the Street’s forecast by 8.8%. On an adjusted basis, it reported a loss of $0.96 per share, falling below the Street’s estimates...
Via
Talk Markets
Guardant Health to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit
August 06, 2021
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health, inc (GH) Q2 2021 Earnings Call Transcript
August 06, 2021
GH earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Precision Oncology Sales Boost Guardant Health Q2 Topline, Backs FY21 Outlook, Management Updates
August 06, 2021
After the market close on Thursday, Guardant Health Inc (NASDAQ: GH) reported Q2 revenues increased 39% Y/Y to $92.1 million, beating the consensus of $84.61...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
August 05, 2021
Gainers Sensus Healthcare (NASDAQ:SRTS) ...
Via
Benzinga
Guardant Health Announces New Leadership Structure Aligned with Strategic Growth Objectives and Expands Board of Directors
August 05, 2021
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Reports Second Quarter 2021 Financial Results
August 05, 2021
From
Guardant Health, Inc.
Via
Business Wire
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
August 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)...
Via
Benzinga
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.